How Will the Market React to Sol Gel Technologies Ltd (SLGL) Stock Getting a Bearish Rating

Thursday, August 10, 2023 11:24 AM | InvestorsObserver Analysts

Mentioned in this article

How Will the Market React to Sol Gel Technologies Ltd (SLGL) Stock Getting a Bearish Rating

Overall market sentiment has been down on Sol Gel Technologies Ltd (SLGL) stock lately. SLGL receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Sol Gel Technologies Ltd has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on SLGL!

See Full SLGL Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With SLGL Stock Today?

Sol Gel Technologies Ltd (SLGL) stock is trading at $3.45 as of 9:30 AM on Thursday, Aug 10, an increase of $0.29, or 9.18% from the previous closing price of $3.16. The stock has traded between $3.45 and $3.45 so far today. Volume today is low. So far 1,930 shares have traded compared to average volume of 15,683 shares.

More About Sol Gel Technologies Ltd

Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications. Click Here to get the full Stock Report for Sol Gel Technologies Ltd stock.